jain.com

Nasdaq delisting and OTC trading commencement

Company: Core Scientific

This claim was withdrawn on September 14, 2026. The quoted passages and the OTC/CORZQ/CRZWQ details are in the source, but the source contradicts two parts of the claim: December 22, 2022 was when Nasdaq issued its Delisting Notice, not when the stock was delisted (trading was suspended January 3, 2023), and that notice cited the Chapter 11 Cases, while the minimum bid price issue was a separate December 13, 2022 deficiency notice.

How this was decided: Evidence review against the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
regulatory
Statement date
2023-04-03
Current status
withdrawn

The claim, verbatim

Common stock delisted from Nasdaq on December 22, 2022 due to failure to maintain minimum bid price and Chapter 11 bankruptcy concerns; began trading on OTC Markets on January 3, 2023 under symbols CORZQ (common stock) and CRZWQ (warrants)

Source (primary)

Core Scientific 10-K filed 2023-04-04 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗

Quote: “On December 22, 2022, the Company received written notice (the "Delisting Notice") from Nasdaq... the staff of Nasdaq had determined that the Company's common stock would be delisted from Nasdaq... Trading of the Company's securities was suspended at the opening of business on January 3, 2023, and our common stock and the common stock warrants began trading on the OTC Markets, operated by the OTC Markets Group, Inc, under the symbols "CORZQ" and "CRZWQ"”

How we checked this

Checked on September 21, 2026. The cited source supports every part of this claim.

The document establishes the December 22, 2022 delisting determination, both cited reasons, and the January 3, 2023 OTC trading start under the two symbols.

Confirmed in the source:

What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000162828023010454/core-20221231.htm) in full (860,799 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms Core Scientific 10-K filed 2023-04-04

Quote: “On December 22, 2022, the Company received written notice (the "Delisting Notice") from Nasdaq... the staff of Nasdaq had determined that the Company's common stock would be delisted from Nasdaq... Trading of the Company's securities was suspended at the opening of business on January 3, 2023, and our common stock and the common stock warrants began trading on the OTC Markets, operated by the OTC Markets Group, Inc, under the symbols "CORZQ" and "CRZWQ"”

View cached copy (2026-09-13)Live source ↗

Record of changes

September 13, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 14, 2026 — withdrawn
Evidence review against the cited source. The quoted passages and the OTC/CORZQ/CRZWQ details are in the source, but the source contradicts two parts of the claim: December 22, 2022 was when Nasdaq issued its Delisting Notice, not when the stock was delisted (trading was suspended January 3, 2023), and that notice cited the Chapter 11 Cases, while the minimum bid price issue was a separate December 13, 2022 deficiency notice.